Image

Balance Confidence and Kinesiophobia in Parkinson's Disease

Balance Confidence and Kinesiophobia in Parkinson's Disease

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

31 patients aged 50-80 years diagnosed with idiopathic Parkinson's disease (Modified Hoehn-Yahr stages 1-3) and 31 healthy volunteers. At the start of the study, sociodemographic data for all participants will be recorded. To assess the mental and functional status of Parkinson's disease patients, the Mini-Mental State Examination (MMSE) and the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) will be used. Balance confidence levels will be assessed using the Activities-specific Balance Confidence Scale-6 (ABC-6), overall balance using the Berg Balance Scale (BBS), fear of falling using the Falls Efficacy Scale (FES), and kinesiophobia levels using the Tampa Scale of Kinesiophobia (TSK).

Eligibility

Inclusion Criteria:

  • Diagnosis of Idiopathic Parkinson's Disease by a neurology specialist.
  • Modified Hoehn-Yahr Staging Scale classification between stages 1-3.
  • Mini-Mental State Examination (MMSE) score of 24 or higher.
  • Age between 50-80 years.
  • Volunteered to participate in the study.

Exclusion Criteria:

  • Use of medications, apart from routine Parkinson's disease treatments, that could affect balance or muscle strength.
  • Presence of neurological or musculoskeletal conditions other than Parkinson's disease.
  • Refusal to participate in the study.
  • Presence of psychiatric disorders.
  • Presence of cognitive impairments.

Study details
    Parkinson Disease

NCT06751797

Beylikduzu State Hospital

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.